𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Increased interleukin-32 expression in chronic hepatitis B virus-infected liver

✍ Scribed by Xu, Qihuan; Pan, Xingfei; Shu, Xin; Cao, Hong; Li, Xuejun; Zhang, Ka; Lu, Jianxi; Zou, Yong; Li, Xueling; Liu, Hongcan; Zhang, Yeqiong; Yang, Daofeng; Ning, Qin; Shen, Guanxin; Li, Gang


Book ID
119298805
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
738 KB
Volume
65
Category
Article
ISSN
0163-4453

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Hepatitis B Virus and HLA Antigen Displa
✍ Luis MontanΜ„to; Guido C. Miescher; Alison H. Goodall; Karl H. Wiedmann; George J πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 651 KB

An analysis of the expression of the histocompatibility antigens in the livers of patients with chronic hepatitis B virus infection and normal subjects has demonstrated an increased expression of HLA-A,B,C antigens on the hepatocytes of patients with a low level of viral replication (HBe antibody po

Hepatitis B virus DNA is frequently foun
✍ Koike, Katsuro; Kobayashi, Midori; Gondo, Morio; Hayashi, Izumi; Osuga, Toshiaki πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 234 KB πŸ‘ 2 views

Human hepatitis B virus (HBV) and hepatitis C virus (HCV) are two major etiologic agents of chronic hepatitis, which is closely related to the development of hepatocellular carcinoma (HCC). A possible involvement of HBV co-infection was investigated in ongoing HCV-related liver diseases in HCV-infec

Acyclovir in chronic hepatitis B virus i
✍ Geoffrey M. Dusheiko πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 273 KB πŸ‘ 2 views

In a previous study a partial inhibition of viral replication was observed in HBeAg-positive patients after acyclovir (ACV) treatment. To assess those results and to evaluate different treatment regimens, a randomized controlled trial with ACV given at 45 mg/kg/day by continuous infusion (in 5 pati

AFP in chronic hepatitis B virus infecti
✍ Yun-Fan Liaw; Anna Lok πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 151 KB πŸ‘ 2 views

to be controlled for in comparing immunoprophylactic approaches. At present, DNA polymerase activity or HBV DNA is useful for estimating the level of exposure. In an editorial in this issue, Dr. Dienstag pointed out difficulties in comparing the results of two immunoprophylactic regimens conducted a